Cell Line Development Market: Current Analysis and Forecast (2022-2028)

Report Description

The cell line development market was valued at USD 4.5 Bn in year 2021 and  is expected to grow at a strong CAGR of around 10% during the forecast period (2022-2030) owing to the increasing demand for biologics and Advancements in cell culture technology. Cell line development is a significant stage in numerous areas of biomedical exploration, including drug discovery, toxicity testing, and the study of disease mechanisms. Biopharmaceuticals like vaccines and monoclonal antibodies are also made with the help of cell lines. Moreover, with increasing awareness about the need and benefits of cell line development technology, spending on product development and R&D activities has increased globally. Burgeoning competition in terms of new players foraying into the cell line development landscape along with evolving favorable regulatory environment, and growing demand for monoclonal antibodies (mAbs) in developed economies are some of the major drivers for the increased penetration of cell line development devices among consumers, especially in the developed and developing countries. Additionally, the rising investments in biopharmaceutical R&D and product launches in the cell line development market are further contributing to the growth of the market.

Some of the major players operating in the market include Schneider GE Healthcare, Lonza, Sartorious AG, WuXi AppTec, Merck KGaA, Selexis SA, Thermo Fisher Scientific Inc., Corning Incorporated, Danaher, ATCC. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst cell line, primary cell line is expected to grow with a significant CAGR during the forecast period”

Based on cell line, the market is segmented into recombinant, hybridomas, continuous cell line, and primary cell line. Amongst these, the primary cell line is expected to grow with a significant CAGR during the forecast period. The increasing demand for high-quality cell lines for drug development and research is driving the primary cell culture market. Additionally, the rising adoption of primary cell lines for therapeutic proteins, manufacturing of vaccines, and increasing use of gene editing technologies, such as CRISPR/Cas9. For instance, the Edit-R CRISPRa Portfolio was introduced by zon Discovery Group in 2020. The Alter R CRISPRa Portfolio is an assortment of plasmids that utilizes CRISPR enactment (CRISPRa) innovation to turn on the statement of explicit qualities in mammalian cells.

“Amongst application, Vaccine production held a major share of the market in 2021”

By application, the market is segmented into recombinant protein expression, hybridomas technology, vaccine production, drug discovery, and others. Vaccine production held a major share of the market in 2021 attributed to the need to update existing vaccine formulations and the emergence of new infectious diseases, the demand for vaccines has increased nowadays. This has prompted an expanded interest in cell lines that can be utilized for immunization creation.

“Asia-Pacific expected to grow”

Asia-Pacific is expected to grow with a significant CAGR during the forecast period due to the growing adoption of CRISPR technology in agriculture and animal breeding, the rising prevalence of genetic disorders, and increased investments in gene editing research. In addition, market expansion in developing nations is being driven by rising government investments in research and development and granted patents for these technologies to develop novel treatments. For instance, the Dublin-based ERS Genomics granted a CRISPR-Cas9 patent to the Japanese biotech company Setsuro Tech in March 2021. With the assistance of these trend-setting innovations, the organization is creating cell and creature models.

Cell Line Development Market Report Coverage

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global cell line development market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Cell Line Development Market Analysis (2022-2028)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global cell line development market were the three major steps undertaken to create and analyze the adoption of cell line development in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global cell line development market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the cell line development market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the cell line development market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as cell line, product, source, and application. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the cell line development market. Further, we conducted factor analysis using dependent and independent variables such as cell line, product, source, and application of the cell line development market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the cell line development market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global cell line development market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the cell line development market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global cell line development market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global cell line development market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the cell line, product, source, and application in the global cell line development market.

The main objective of the Global Cell line development Market Study

The current & future market trends of the global cell line development market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• • Analyze the current and forecast market size of the cell line development market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of the cell line, product, source, and application
  • Define and analysis of the regulatory framework for the cell line development industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the cell line development market for the major region
  • Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
  • Company profiles of the cell line development market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team